The hydroxypyridinone iron chelator CP94 increases methyl-aminolevulinate-based photodynamic cell killing by increasing the generation of reactive oxygen species

Methyl-aminolevulinate-based photodynamic therapy (MAL-PDT) is utilised clinically for the treatment of non-melanoma skin cancers and pre-cancers and the hydroxypyridinone iron chelator, CP94, has successfully been demonstrated to increase MAL-PDT efficacy in an initial clinical pilot study. However...

Descripción completa

Detalles Bibliográficos
Autores principales: Dogra, Yuktee, Ferguson, Daniel C.J., Dodd, Nicholas J.F., Smerdon, Gary R., Curnow, Alison, Winyard, Paul G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961297/
https://www.ncbi.nlm.nih.gov/pubmed/27454766
http://dx.doi.org/10.1016/j.redox.2016.07.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961297/
https://www.ncbi.nlm.nih.gov/pubmed/27454766
http://dx.doi.org/10.1016/j.redox.2016.07.002

Ejemplares similares